Caladrius Biosciences Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
9.73 M |
Public Float |
7.26 M |
Caladrius Biosciences Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.58 |
Market Cap |
$26.06 M |
Shares Outstanding |
10.39 M |
Public Float |
8.68 M |
Address |
110 Allen Road Basking Ridge New Jersey 07920 United States |
Employees | - |
Website | http://www.caladrius.com |
Updated | 07/08/2019 |
Caladrius Biosciences, Inc. operates as a global healthcare company, which engages in developing cellular therapies that repair damaged tissue, cells and organs and restore their normal function. It is pursuing the preservation and enhancement of human health globally through the development of cell based therapeutics that prevent, treat or cure disease. Its business includes the development of novel proprietary cell therapy products, as well as a revenue-generating contract development and manufacturing service business that it leverages for the development of therapeutics while providing service to other companies in the cell therapy industry developing products. |